The Oncology Institute, Inc. (TOI) Misses Q2 EPS by 4c, Offers Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. SAP
6. CSX
7. LRCX
8. LVS
9. QGEN
10. SPY

Go back to The Oncology Institute, Inc. (TOI) Misses Q2 EPS by 4c, Offers Guidance

The Oncology Institute Reports Second Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance

August 8, 2023 4:40 PM EDT

CERRITOS, Calif., Aug. 08, 2023 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (TOI or the Company), one of the largest value-based community oncology groups in the United States, today reported financial results for its three and six months ended June 30, 2023 and reaffirmed its full year 2023 guidance.

Recent Operational Highlights:

Completed the acquisition of Southland Radiation Oncology Network (SRON)Signed a new partnership with Massive Bio to further enhance randomization of trialsIncreased patient visits 14% compared to... More